Pfizer and its partner BioNTech on Friday asked the Food and Drug Administration to release the coronavirus vaccine for children aged 12 to 15, just one week after the companies said a late-stage study showed that the vaccine was very effective in this age group. .
If U.S. regulators approve the request, Pfizer’s lap will be the first to be available to younger teens. The move could also accelerate the timeline for returning more students and combating costly safety measures being considered by education systems.
Of the three vaccines already in use in the United States, Pfizer’s shot is the only one now allowed for 16- and 17-year-olds.